Quick Answer
Upstream Bio, Inc. reported Total Revenue of $2.85 million for fiscal year 2025.
Upstream Bio, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $2.85M | +20.4% |
| 2024 | $2.37M | -0.4% |
| 2023 | $2.38M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $683.0K | +12.5% | -27.1% |
| June 30, 2025 | $937.0K | +83.7% | +65.5% |
| March 31, 2025 | $566.0K | -11.6% | -6.8% |
| September 30, 2024 | $607.0K | -2.3% | +19.0% |
| June 30, 2024 | $510.0K | — | -20.3% |
| March 31, 2024 | $640.0K | — | +3.1% |
| September 30, 2023 | $621.0K | — | — |
- Upstream Bio, Inc. showed an increase of +20.4% in Total Revenue compared to the prior fiscal year.
- Over the 2023–2025 period, Upstream Bio, Inc.’s total revenue has grown by 19.9% (from $2.38 million to $2.85 million).
- The most recent figure is from Upstream Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: